GSGrigorii V. Sorokoletov

Grigorii V. Sorokoletov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Grigorii V. Sorokoletov has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Analysis of quantitative optical coherence tomography angiography parameters after one-stage combined treatment of primary open-angle glaucoma and complicated cataract

    by Natalia A. Morina, Морина Наталья Александровна, Краснова Екатерина Олеговна, Ekaterina O. Krasnova, Tatyana V. Sokolovskaya, Соколовская Татьяна Викторовна, Grigory V. Sorokoletov, Сороколетов Григорий Владимирович

    BACKGROUND: Despite the widespread adoption of micropulse laser cyclophotocoagulation in clinical practice, data on its use as part of one-stage combined treatment for primary open-angle glaucoma and complicated cataract remain limited. In particular, changes in the quantitative parameters of the macular region, as assessed by optical coherence tomography angiography, after combining phacoemulsification of cataract and micropulse cyclophotocoagulation have not been sufficiently studied. AIM: To analyze the changes in the quantitative parameters of the vascular system of the macular region based on optical coherence tomography angiography data after one-stage combined laser surgical treatment of primary open-angle glaucoma and complicated cataract. METHODS: The study included patients with complicated cataracts in combination with primary open-angle glaucoma at the initial and advanced stages, who had not previously undergone surgery for glaucoma or other ophthalmic pathologies. All patients underwent one-stage combined treatment, which included phacoemulsification of the cataract with implantation of an intraocular lens and micropulse cyclophotocoagulation. In addition to the standard ophthalmological examination, optical coherence tomography angiography of the macular region was performed according to the Angiography 6 × 6 mm protocol, with assessment of perfusion density, vessel density, and parameters of the foveal avascular zone. The study was carried out before surgery, and 1 and 6 months after the intervention. RESULTS: Initially, 31 patients (36 eyes) were included in the study; after excluding 2 patients, the final analysis was performed on 29 patients (34 eyes). After the surgery, a statistically significant increase in best-corrected visual acuity was observed (an increase of 0.51 at 6 months [95% CI 0.44–0.59], p 0.001), as well as a statistically significant reduction in intraocular pressure (by 3.18 mm Hg at 1 month [95% CI 1.56–4.79], p 0.001), followed by stabilization of the value at 6 months. According to optical coherence tomography angiography, statistically significant changes in perfusion density and vessel density were detected: 1 month after surgery, an increase in these parameters compared to preoperative values was observed; subsequently, a tendency toward their reduction was noted, with a return to the initial parameters. No statistically significant changes were found for the quantitative indicators of the foveal avascular zone. CONCLUSION: One-stage combined treatment of primary open-angle glaucoma and complicated cataract is not accompanied by clinically significant adverse changes in macular hemodynamics according to optical coherence tomography angiography. The detected changes in perfusion density and vascular density parameters are moderate and transient, reaching maximum severity in the early postoperative period and demonstrating a tendency toward stabilization in the long-term postoperative period.

  • Open Access

    Morphological changes in the sclera after implantation of a new intrascleral implant in an ex vivo experiment

    by K. I. Slastina, G. V. Sorokoletov, S. A. Borzenok, D. S. Ostrovskiy, M. Kh. Khubetsova, М. Х. Хубецова

    PURPOSE. To evaluate the morphological features of implantation of a new intrascleral implant (ISI) made of polymethyl methacrylate in an ex vivo experiment. METHODS. The ex vivo experiment was conducted on scleral fragments obtained from the equatorial region of the eyes of cadaveric donors aged 40–60 years. The study group included eight scleral fragments in which the ISI was implanted during simulated glaucoma surgery (GS), while the control group consisted of eight scleral fragments subjected to GS without implantation. Organotypic cultivation was performed in a standard medium under normothermic conditions for 6 months. At 14, 30, 90, and 180 days, two fragments from each group were removed from the culture for scanning electron microscopy and immunohistochemical analysis. RESULTS. Morphological findings demonstrated that the presence of the investigated ISI in cadaveric sclera did not induce an active proliferative cellular response throughout the entire observation period (up to 6 months). CONCLUSION. The developed polymethyl methacrylate ISI shows promise for further clinical trials in glaucoma surgery.

  • Experimental study of a new anti-glaucoma intrascleral implant

    by K.I. Slastina, G.V. Sorokoletov, I.G. Trifanenkova, M.A. Plakhotniy, E.V. Erokhina, D.G. Uzunyan

    Purpose. This study consisted of an in vivo experiment with the goal of performing instrumental evaluation of the position of a novel anti-glaucoma intrascleral implant. Material and methods. This in vivo study was conducted on 5 Chinchilla rabbits (n=5). The main group included 5 right eyes that underwent glaucoma surgery with implantation of the device. The comparison group consisted of 5 left eyes that underwent glaucoma surgery without implant placement. Animals in both groups were followed up for 3 months with biomicroscopy, ultrasound biomicroscopy, and optical coherence tomography (OCT) of the surgery area. At the end of the observation period, the rabbits were removed from the experiment for further research. Results. The developed intrascleral implant maintained correct position and was clearly visualized within the scleral tissue in animals of the main group throughout the entire observation period (up to 3 months). Conclusion. The new anti-glaucoma intrascleral implant made of polymethylmethacrylate is promising for further research.

  • Corneal endothelium status as a criterion for assessing the safety of the technique in the combined treatment of patients with glaucoma and cataract

    by E. O. Krasnova, G. V. Sorokoletov, T. V. Sokolovskaya

    PURPOSE. To evaluate corneal endothelial status in patients with primary open-angle glaucoma and complicated cataract undergoing combined micropulse transscleral cyclophotocoagulation (MP-CPC) and cataract phacoemulsification with intraocular lens implantation (PE+IOL). METHODS. This prospective study included 62 patients with stage I–II primary open-angle glaucoma and complicated cataract who underwent surgical treatment. The study group comprised 33 patients who received combined intervention (MP-CPC+PE+IOL), while the control group included 32 patients who only underwent PE+IOL. Corneal endothelial status was assessed using the Tomey EM-3000 specular microscope preoperatively and at 1, 3, 6, and 12 months after surgery. RESULTS. In both groups, a moderate decrease in endothelial cell density was observed during the early postoperative period, with the most pronounced reduction at 1 month (up to 11.8%), followed by stabilization. At 12 months, the mean endothelial cell loss was less than 10%, with no statistically significant differences between the groups (p>0.05). Best-corrected visual acuity improved significantly compared with baseline. No progression of glaucomatous damage was detected by perimetry and optical coherence tomography. The incidence of postoperative intraocular pressure elevation was comparable between the groups. CONCLUSION. The combined use of MP-CPC and PE+IOL demonstrates a satisfactory safety profile and does not exert a significant negative effect on corneal endothelial status compared with isolated phacoemulsification. The obtained results support the feasibility of the combined approach in patients with concomitant ophthalmic pathology.

  • Open Access

    Outcomes of combined surgical treatment of glaucoma and cataract in complicated cases

    by G. V. Sorokoletov, O. S. Kolysheva, M. R. Taevere

    PURPOSE. To evaluate the effectiveness and safety of combined surgical treatment for primary open-angle glaucoma (POAG) and cataract in patients with grade I–II lens subluxation due to pseudoexfoliation syndrome (PEX). The study analyzed early outcomes of phacoemulsification (PE) with optic capture fixation of the intraocular lens (IOL) and non-penetrating deep sclerectomy (NPDS) using the Healaflow drainage in the presence of zonular weakness. METHODS. The study included 20 patients (20 eyes) with stage II–III POAG, age-related cataract, and grade I–II lens subluxation associated with PEX. All patients (mean age 73 years) underwent simultaneous phacoemulsification with implantation of an AcrySof MA60AC IOL (Alcon) using the optic capture technique and NPDS with Healaflow. Uncorrected (UCVA) and best-corrected visual acuity (BCVA), intraocular pressure (IOP), tonographic parameters, static perimetry, and optical coherence tomography (OCT) findings were evaluated over 12 months. RESULTS. At 12 months, UCVA improved from 0.07±0.06 to 0.35±0.22 (pCONCLUSION. The combined approach to the treatment of POAG, cataract, and lens subluxation associated with PEX provided sustained IOP reduction, improved visual function, and maintained IOL stability. The optic capture technique proved effective for IOL fixation in cases with zonular weakness, while NPDS with Healaflow ensured safe glaucoma control. Further long-term studies with larger cohorts are warranted to confirm these findings.


  • Open Access

    Implantation of Ahmed drainage device in secondary “silicone” glaucoma. Features of the postoperative course

    by Anna V. Starostina, Alla V. Sidorova, Aila A. Uyanaeva, Grigorii V. Sorokoletov, Konstantin S. Burlakov, Уянаева Айла Азретовна

    BACKGROUND: Despite the high technological effectiveness of treatment methods for vitreoretinal conditions, secondary glaucoma is a fairly common complication in the postoperative period, especially after tamponade with silicone oil. AIM: The aim of this study is to evaluate the effectiveness of Ahmed valve drainage device implantation in secondary glaucoma after vitreoretinal surgery with silicone oil tamponade and after the silicone oil removal. MATERIALS AND METHODS: The study included 42 patients with secondary glaucoma after vitreoretinal procedures with silicone oil tamponade for rhegmatogenous retinal detachment. Patients were divided into two groups: group 1 included 27 patients with avitria after silicone oil removal, group 2 — 15 patients with silicone oil tamponade in whom silicone oil removal was not indicated for various reasons. Before surgery, decompensation of intraocular pressure was detected in all patients (32.5 ± 2.9 mmHg, at the maximum hypotensive regimen), visual acuity varied from counting fingers to 0.5 with no correction of refractive error possible. RESULTS: In all cases, anti-glaucoma surgeries with Ahmed valve implantation were performed without complications. In the early postoperative period, the hypotensive effect was achieved in 100% of cases in both groups, the level of intraocular pressure on the first day after surgery in patients with avitria after removal of silicone oil averaged 9.3 ± 1.5 mmHg, in the group with silicone oil in the vitreal cavity — 10.2 ± 1.8 mmHg. The most common complication in the early postoperative period in patients with silicone oil tamponade was a shallow anterior chamber (in 40% of cases). Intraocular pressure was compensated in all patients within 12 months. CONCLUSIONS: The use of Ahmed drainage device is an effective method of intraocular pressure normalization in patients with secondary glaucoma after vitreoretinal procedures, both with silicone oil tamponade and avitria.